Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis
- Sponsor
- Assiut University
- Study ID
- NCT07383805
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Jan 2026
- Primary completion
- Sep 1, 2026
- Completion
- Sep 1, 2029
Study Design
- Enrollment
- 81 participants (estimated)
Primary Outcome Measure
To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients [ Time Frame: through study completion, an average of 1 year ]
Central Contacts
- Eman Safwat, MD01014116158
Related Studies
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Exactech Shoulder Post Market Clinical Follow-up StudyRecruiting · Exactech · Laguna Woods, California
- IMPACT - AndHealth Autoimmune Research RegistryRecruiting · AndHealth · Columbus, Ohio